Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT

<div>Comparison of patients’ ARR (<i>n</i> (%)). The horizontal axis from left to right indicates the skin reactions, gastrointestinal reactions, hepatorenal reactions, rash, fatigue and drowsiness, and hyperbilirubinemia, and the vertical axis indicates the cases (<i>n</i>); the black areas indicate group A and the gray areas indicate group B.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT 